Update on New and Emerging Treatments for Schizophrenia.
Psychiatr Clin North Am
; 39(2): 217-38, 2016 06.
Article
em En
| MEDLINE
| ID: mdl-27216901
ABSTRACT
Although there has been more than 50 years of development, there remains a great need for better antipsychotic medications. This article looks at the recent advances in treatment of schizophrenia. New hypotheses have been suggested that may replace or complement the dopamine hypotheses. The article explores the different novel drugs that impact some of the key neurotransmitter systems currently. Phosphodiesterase 10A inhibitors and α-7 neuronal nicotinic acetylcholine receptor modulators constitute the majority. The marketing of these medications eventually may result in change about how schizophrenia is treated.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Esquizofrenia
/
Antipsicóticos
/
Aprovação de Drogas
Limite:
Humans
Idioma:
En
Revista:
Psychiatr Clin North Am
Ano de publicação:
2016
Tipo de documento:
Article